Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-29

Protein biochip array technology for diagnosis of Alzheimer's disease in blood platelets

Obiettivo

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with an ever-increasing incidence in the aged population. However, there is no definitive diagnostic test for Alzheimer's disease. AD patients are only probably detected at a progressed stage of the disease when neurodegeneration already occurred and the possibilities of treatment are reduced. In the proposed project, the Medical University of Vienna in Austria and the diagnostic company Randox Laboratories Ltd. in the UK join their expertise to develop a blood test for AD with the potential scientific background that blood platelets mirror AD-related alteration of the central nervous system.

In a clinical study the University has already identified 21 new AD-specific platelet proteins by difference two dimensional gel electrophoresis (DIGE). The proposed project combines the brand-new CyDye DIGE proteomic method with innovative Protein Biochip Array Technology of the Company. It aims to develop a Biochip, which detects the AD-specific proteins in blood platelets. An intensive transfer of knowledge between the two partners is necessary to achieve this goal. Mutual exchange of researchers for two years would accelerate the development of a diagnostic AD Biochip. University researchers will participate in production of antibodies and in the setup of a Protein Biochip Array at the Company. Company's researchers will learn platelet preparation, evaluate antibodies and clinical evaluation of the experimental Biochips at the University.

This exchange of researchers will overcome the gap between academia and industry. The techniques developed in the course of this collaboration will open new possibilities, which go far beyond the proposed project. This includes analysis of platelets from patients with other diseases such as diabetes or cardiovascular disease as well as analysis of other blood cells. Thus, the proposed project will constitute the basis for lasting inter-sectorial research collaboration.

Campo scientifico (EuroSciVoc)

Parole chiave

Argomento(i)

Invito a presentare proposte

FP6-2004-MOBILITY-3
Vedi altri progetti per questo bando

Meccanismo di finanziamento

TOK - Marie Curie actions-Transfer of Knowledge

Coordinatore

MEDICAL UNIVERSITY OF VIENNA
Contributo UE
Nessun dato
Costo totale
Nessun dato

Partecipanti (1)